Xylem Market Sentiment

Xylem Inc

XYLNYSE

$92.40

1.641.81%

Últ. Act.: Oct 30, 4:53 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Dividendos Comparar Opciones Informe de acciones

Ganancias: Los beneficios de Q3 2026 se publicaron el mar oct 27th, antes de la apertura del mercado

Conferencia telefónica: La conferencia telefónica más reciente comenzó a las 9:00 a. m., hace 4 días

Haz clic para ver el webcast

Xylem Market Sentiment - Benzinga

Xylem Market Sentiment

Market sentiment signals for Xylem (XYL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 5.9% short float

Options Flow▲ 0.42 P/C ratio

Insider Activity▲ Net Buyer (30d)

Analyst Consensus

Buy

22 analysts

Options Flow (P/C)

0.42

More calls — Bullish

1,263 calls · 536 puts

Avg Consensus PT

$133

+43.2%

Highest Price Target

$175

+88.8%

UBS

Lowest Price Target

$90

-2.9%

JP Morgan

Short Interest

5.9%

Rising — Bearish

Insider Activity (30d)

Net Buyer

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 29, 2026	UBS	Joshua Spector—	+6.8%	$112 → $99	Maintained	Neutral
Oct 29, 2026	Barclays	William Grippin—	+12.2%	$139 → $104	Downgrade	Overweight→Equal-Weight
Oct 28, 2026	Citigroup	Andrew Kaplowitz—	+40.2%	$148 → $130	Maintained	Buy
Oct 28, 2026	BNP Paribas	Andrew Buscaglia—	+45.6%	$145 → $135	Maintained	Outperform
Oct 28, 2026	Goldman Sachs	Brian Lee—	+48.9%	$160 → $138	Maintained	Buy
Oct 28, 2026	Stifel	Nathan Jones—	+23.0%	$141 → $114	Maintained	Buy
Oct 28, 2026	RBC Capital	Jeffrey Reive—	+34.8%	$135 → $125	Maintained	Outperform
Oct 28, 2026	Oppenheimer	Bryan Blair—	+45.6%	$150 → $135	Maintained	Outperform
Oct 28, 2026	JP Morgan	Michael Fairbanks—	-2.9%	$118 → $90	Downgrade	Neutral→Underweight
Oct 19, 2026	JP Morgan	Mark Strouse—	+27.3%	$137 → $118	Maintained	Neutral
Oct 15, 2026	Mizuho	Brett Linzey—	+18.7%	$130 → $110	Maintained	Neutral
Oct 14, 2026	Oppenheimer	Bryan Blair—	+61.8%	$158 → $150	Maintained	Outperform
Oct 14, 2026	RBC Capital	Jeffrey Reive—	+45.6%	$164 → $135	Maintained	Outperform
Oct 13, 2026	Barclays	William Grippin—	+49.9%	$159 → $139	Maintained	Overweight
Oct 12, 2026	Citigroup	Andrew Kaplowitz—	+59.7%	$172 → $148	Maintained	Buy
Oct 5, 2026	UBS	Joshua Spector—	+20.8%	$138 → $112	Maintained	Neutral
Sep 15, 2026	Wolfe Research	Nigel Coe—	—	—	Assumes	Peer Perform
Aug 24, 2026	Jefferies	Stephen Volkmann—	+61.8%	$145 → $150	Maintained	Buy
Aug 13, 2026	UBS	Joshua Spector—	+48.9%	$135 → $138	Maintained	Neutral
Jul 30, 2026	UBS	Joshua Spector—	+45.6%	$129 → $135	Maintained	Neutral
Jul 29, 2026	Stifel	Nathan Jones—	+72.6%	$157 → $160	Maintained	Buy
Jul 29, 2026	Mizuho	Brett Linzey—	+40.2%	$124 → $130	Maintained	Neutral
Jul 29, 2026	RBC Capital	Deane Dray—	+76.9%	$159 → $164	Maintained	Outperform
Jul 29, 2026	Barclays	William Grippin—	+71.5%	$154 → $159	Maintained	Overweight
Jul 29, 2026	Baird	Michael Halloran—	+78.0%	$163 → $165	Maintained	Outperform